<?xml version='1.0' encoding='utf-8'?>
<document id="12590402"><sentence text="Mirtazapine in combination with amitriptyline: a drug-drug interaction study in healthy subjects."><entity charOffset="0-11" id="DDI-PubMed.12590402.s1.e0" text="Mirtazapine" /><entity charOffset="32-45" id="DDI-PubMed.12590402.s1.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.12590402.s1.e0" e2="DDI-PubMed.12590402.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s1.e0" e2="DDI-PubMed.12590402.s1.e1" /></sentence><sentence text="To assess the steady-state pharmacokinetics of mirtazapine (30 mg/day orally) and amitriptyline (75 mg/day orally) during combined administration compared with that of either drug administered alone"><entity charOffset="47-58" id="DDI-PubMed.12590402.s2.e0" text="mirtazapine" /><entity charOffset="82-95" id="DDI-PubMed.12590402.s2.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.12590402.s2.e0" e2="DDI-PubMed.12590402.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s2.e0" e2="DDI-PubMed.12590402.s2.e1" /></sentence><sentence text=" To evaluate the tolerability and effects on psychometric tests of acute and subchronic administration of both drugs combined and alone" /><sentence text="" /><sentence text="In a single-blind, three-way cross-over study, 24 (12 male and 12 female) healthy subjects were randomly assigned to six different sequences of three 9-day treatments, i" /><sentence text="e" /><sentence text=" racemic mirtazapine (30 mg/day), amitriptyline (75 mg/day) or the combination of these drugs"><entity charOffset="34-47" id="DDI-PubMed.12590402.s7.e0" text="amitriptyline" /></sentence><sentence text=" To control for acute pharmacodynamic assessments, during the first treatment period, a placebo group (n = 8; 4 females and 4 males) was added" /><sentence text=" Serial blood samples were drawn for plasma level measurements that were subsequently subjected to pharmacokinetic analysis" /><sentence text=" Psychometric tests assessed attentional performance, and a computer-assisted telephone questionnaire assessed self-ratings of drowsiness/alertness and sleep quality" /><sentence text="" /><sentence text="Amitriptyline increased the C(max) of mirtazapine (+ 36%, p &lt; 0"><entity charOffset="0-13" id="DDI-PubMed.12590402.s12.e0" text="Amitriptyline" /><entity charOffset="38-49" id="DDI-PubMed.12590402.s12.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.12590402.s12.e0" e2="DDI-PubMed.12590402.s12.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s12.e0" e2="DDI-PubMed.12590402.s12.e1" /></sentence><sentence text="05) in male subjects only" /><sentence text=" Mirtazapine altered the C(max) of amitriptyline in both male (+ 23%, p &lt; 0"><entity charOffset="1-12" id="DDI-PubMed.12590402.s14.e0" text="Mirtazapine" /><entity charOffset="35-48" id="DDI-PubMed.12590402.s14.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.12590402.s14.e0" e2="DDI-PubMed.12590402.s14.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s14.e0" e2="DDI-PubMed.12590402.s14.e1" /></sentence><sentence text="05) and female (- 23%, p &lt; 0" /><sentence text="05) subjects" /><sentence text=" No changes were observed for other pharmacokinetic parameters" /><sentence text=" Metabolite parameters were not affected" /><sentence text=" Changes in parent compound levels mainly resulted from effects on absorption" /><sentence text=" The psychometric test results did not reveal significant changes between combined and single drug treatments" /><sentence text=" The telephone registrations of VAMRS and LSEQ did not show clinically relevant differences between the active treatments" /><sentence text="" /><sentence text="Combined administration of mirtazapine (30 mg/day) and amitriptyline (75 mg/day) alters the pharmacokinetics of either compound to a minor extent"><entity charOffset="27-38" id="DDI-PubMed.12590402.s23.e0" text="mirtazapine" /><entity charOffset="55-68" id="DDI-PubMed.12590402.s23.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.12590402.s23.e0" e2="DDI-PubMed.12590402.s23.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s23.e0" e2="DDI-PubMed.12590402.s23.e1" /></sentence><sentence text=" Adding one drug to the other and substituting one drug by the other had no major effects on tolerability" /><sentence text=" Nevertheless, caution is warranted when combining amitriptyline and mirtazapine"><entity charOffset="51-64" id="DDI-PubMed.12590402.s25.e0" text="amitriptyline" /><entity charOffset="69-80" id="DDI-PubMed.12590402.s25.e1" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.12590402.s25.e0" e2="DDI-PubMed.12590402.s25.e0" /><pair ddi="false" e1="DDI-PubMed.12590402.s25.e0" e2="DDI-PubMed.12590402.s25.e1" /></sentence><sentence text="" /></document>